These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8060130

  • 1. [Strategy of treatment for pancreatic and biliary cancer with special reference to immunotherapy].
    Oka M, Suzuki T.
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1571-6. PubMed ID: 8060130
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S.
    Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
    [Abstract] [Full Text] [Related]

  • 5. [Adoptive immunotherapy using MUC1--specific CTLs for unresectable pancreatic cancer].
    Kawaoka T, Takashima M, Yamamoto K, Ueno T, Oka M.
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():279-82. PubMed ID: 16457266
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Current diagnosis and combined and radiation therapy of pancreato-biliary cancer in patients with jaundice].
    Kharchenko VP, Liumfaliev TA, Khmelevskiĭ EV, Galil-Ogly GA, Kunda MA.
    Vopr Onkol; 1999 Jan; 45(1):59-65. PubMed ID: 10941368
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
    Nanashima A, Yamaguchi H, Sumida Y, Abo T, Tobinaga S, Tanaka K, Takeshita H, Hidaka S, Sawai T, Yasutake T, Nagayasu T.
    Hepatogastroenterology; 2008 Jan; 55(84):873-8. PubMed ID: 18705286
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M, Wada J, Suzuki H, Tanaka M, Katano M, Morisaki T.
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [Abstract] [Full Text] [Related]

  • 12. Tumor specific CTL therapy for advanced cancer and development for cancer vaccine.
    Tsunoda T, Tanimura H, Yamaue H, Tanaka H, Matsuda K.
    Hepatogastroenterology; 1999 May; 46 Suppl 1():1287-92. PubMed ID: 10429976
    [Abstract] [Full Text] [Related]

  • 13. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T, Kato H, Matsushiro T, Nimura Y, Nagakawa T, Nakayama T, Yamauchi H, Ogata Y, Shimada H, Miyakawa S, Yamaguchi A, Sakoda K, Yasuda H, Tsukada K, Yoshida K, Ashida H, Ishikawa Y, Kotoura Y, Kinoshita H, Kajiwara T, Watanabe G, Uchimura M, Funabiki T, Ikeda S, Okada S.
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [Abstract] [Full Text] [Related]

  • 14. [Chemoradiotherapy for locally recurrence after primary resection of biliary-pancreatic cancer].
    Maemura K, Shinchi H, Noma H, Mataki Y, Kurahara H, Maeda S, Natsugoe S, Takao S.
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):265-8. PubMed ID: 19223743
    [Abstract] [Full Text] [Related]

  • 15. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
    Schmidt T, Ziske C, Märten A, Endres S, Tiemann K, Schmitz V, Gorschlüter M, Schneider C, Sauerbruch T, Schmidt-Wolf IG.
    Cancer Res; 2003 Dec 15; 63(24):8962-7. PubMed ID: 14695214
    [Abstract] [Full Text] [Related]

  • 16. A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract.
    Czito BG, Hong TJ, Cohen DP, Petros WP, Tyler DS, Pappas TN, Yu D, Lee CG, Lockhart AC, Morse MA, Fernando N, Hurwitz HI.
    Cancer Invest; 2006 Feb 15; 24(1):9-17. PubMed ID: 16466986
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of intraportal adoptive immunotherapy on liver metastases after resection of pancreatic cancer.
    Kobari M, Egawa S, Shibuya K, Sunamura M, Saitoh K, Matsuno S.
    Br J Surg; 2000 Jan 15; 87(1):43-8. PubMed ID: 10606909
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.